Complementary and alternative therapeutic approaches in patients with early breast cancer
EGFR signaling pathway in breast cancers
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance
Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours
Provasopressin expression by breast cancer cells
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer